{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:31:52Z","timestamp":1773779512704,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82470203"],"award-info":[{"award-number":["No. 82470203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shaanxi Province Health Blood Tumor Disease Scientific Research Innovation Project","award":["(No.2023TD-03"],"award-info":[{"award-number":["(No.2023TD-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03417-2","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T17:56:54Z","timestamp":1764352614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of a novel frailty model for the patients with newly diagnosed multiple myeloma"],"prefix":"10.1186","volume":"31","author":[{"given":"Biao","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangshuang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenrui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanting","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruochen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxia","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyi","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangxun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"5","key":"3417_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, et al. Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327(5):464\u201377. https:\/\/doi.org\/10.1001\/jama.2022.0003.","journal-title":"JAMA"},{"issue":"3","key":"3417_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1182\/blood.2022017635","volume":"143","author":"T Facon","year":"2024","unstructured":"Facon T, Leleu X, Manier S. How i treat multiple myeloma in geriatric patients. Blood. 2024;143(3):224\u201332. https:\/\/doi.org\/10.1182\/blood.2022017635.","journal-title":"Blood"},{"issue":"2","key":"3417_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1182\/blood-2014-10-609461","volume":"125","author":"PS Rosenberg","year":"2015","unstructured":"Rosenberg PS, Barker KA, Anderson WF. Future distribution of multiple myeloma in the United States by sex, age, and race\/ethnicity. Blood. 2015;125(2):410\u20132. https:\/\/doi.org\/10.1182\/blood-2014-10-609461.","journal-title":"Blood"},{"issue":"5","key":"3417_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/CCO.0000000000000395","volume":"29","author":"S Zweegman","year":"2017","unstructured":"Zweegman S, Engelhardt M, Larocca A. Elderly patients with multiple myeloma: towards a frailty approach? Curr Opin Oncol. 2017;29(5):315\u201321. https:\/\/doi.org\/10.1097\/CCO.0000000000000395.","journal-title":"Curr Opin Oncol"},{"issue":"7","key":"3417_CR5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2217\/fon-2020-0615","volume":"17","author":"H Tang","year":"2021","unstructured":"Tang H, Jia S, Bi L, Jia W, Gao G. Treatment options for older unfit patients with acute myeloid leukemia. Future Oncol. 2021;17(7):837\u201351. https:\/\/doi.org\/10.2217\/fon-2020-0615.","journal-title":"Future Oncol"},{"issue":"5","key":"3417_CR6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/jgs.15715","volume":"67","author":"TM Wildes","year":"2019","unstructured":"Wildes TM, Tuchman SA, Klepin HD, Mikhael J, Trinkaus K, Stockerl Goldstein K, et al. Geriatric assessment in older adults with multiple myeloma. J Am Geriatr Soc. 2019;67(5):987\u201391. https:\/\/doi.org\/10.1111\/jgs.15715.","journal-title":"J Am Geriatr Soc"},{"key":"3417_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac185","author":"EH Gordon","year":"2022","unstructured":"Gordon EH, Hubbard RE. Frailty: understanding the difference between age and ageing. Age Ageing. 2022. https:\/\/doi.org\/10.1093\/ageing\/afac185.","journal-title":"Age Ageing"},{"issue":"6","key":"3417_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1056\/NEJMra2301292","volume":"391","author":"DH Kim","year":"2024","unstructured":"Kim DH, Rockwood K. Frailty in older adults. N Engl J Med. 2024;391(6):538\u201348. https:\/\/doi.org\/10.1056\/NEJMra2301292.","journal-title":"N Engl J Med"},{"issue":"S1","key":"3417_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5045\/br.2022.2021218","volume":"57","author":"JY Choi","year":"2022","unstructured":"Choi JY, Kim KI. Assessing frailty using comprehensive geriatric assessment in older patients with hematologic malignancy. Blood Res. 2022;57(S1):1\u20135. https:\/\/doi.org\/10.5045\/br.2022.2021218.","journal-title":"Blood Res"},{"issue":"1","key":"3417_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jgo.2016.04.001","volume":"8","author":"TM Wildes","year":"2017","unstructured":"Wildes TM, Campagnaro E. Management of multiple myeloma in older adults: gaining ground with geriatric assessment. J Geriatr Oncol. 2017;8(1):1\u20137. https:\/\/doi.org\/10.1016\/j.jgo.2016.04.001.","journal-title":"J Geriatr Oncol"},{"issue":"13","key":"3417_CR11","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","volume":"125","author":"A Palumbo","year":"2015","unstructured":"Palumbo A, Bringhen S, Mateos MV, Larocca A, Facon T, Kumar SK, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an international myeloma working group report. Blood. 2015;125(13):2068\u201374. https:\/\/doi.org\/10.1182\/blood-2014-12-615187.","journal-title":"Blood"},{"issue":"11","key":"3417_CR12","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/ajh.24532","volume":"91","author":"P Milani","year":"2016","unstructured":"Milani P, Vincent Rajkumar S, Merlini G, Kumar S, Gertz MA, Palladini G, et al. N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma. Am J Hematol. 2016;91(11):1129\u201334. https:\/\/doi.org\/10.1002\/ajh.24532.","journal-title":"Am J Hematol"},{"issue":"1","key":"3417_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41375-019-0539-0","volume":"34","author":"T Facon","year":"2020","unstructured":"Facon T, Dimopoulos MA, Meuleman N, Belch A, Mohty M, Chen W, et al. A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the first (mm-020) trial. Leukemia. 2020;34(1):224\u201333. https:\/\/doi.org\/10.1038\/s41375-019-0539-0.","journal-title":"Leukemia"},{"issue":"1","key":"3417_CR14","doi-asserted-by":"publisher","first-page":"22907","DOI":"10.1038\/s41598-021-02433-6","volume":"11","author":"HS Lee","year":"2021","unstructured":"Lee HS, Lee J, Jo JC, Jung SH, Lee JJ, Kim D, et al. Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population. Sci Rep. 2021;11(1):22907. https:\/\/doi.org\/10.1038\/s41598-021-02433-6.","journal-title":"Sci Rep"},{"issue":"1","key":"3417_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1182\/hematology.2021000231","volume":"2021","author":"SJ Grant","year":"2021","unstructured":"Grant SJ, Freeman CL, Rosko AE. Treatment of older adult or frail patients with multiple myeloma. Hematology Am Soc Hematol Educ Program. 2021;2021(1):46\u201354. https:\/\/doi.org\/10.1182\/hematology.2021000231.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"24","key":"3417_CR16","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","volume":"32","author":"H Wildiers","year":"2014","unstructured":"Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen MLG, Extermann M, et al. International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32(24):2595\u2013603. https:\/\/doi.org\/10.1200\/JCO.2013.54.8347.","journal-title":"J Clin Oncol"},{"key":"3417_CR17","doi-asserted-by":"publisher","first-page":"1103687","DOI":"10.3389\/fonc.2023.1103687","volume":"13","author":"Y Chen","year":"2023","unstructured":"Chen Y, Gu J, Huang B, Liu J, Li X, Li J. Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: the tm frailty score. Front Oncol. 2023;13:1103687. https:\/\/doi.org\/10.3389\/fonc.2023.1103687.","journal-title":"Front Oncol"},{"key":"3417_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afab211","author":"Y Yao","year":"2022","unstructured":"Yao Y, Sui WW, Liao AJ, Wang W, Chen LJ, Chu XX, et al. Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study. Age Ageing. 2022. https:\/\/doi.org\/10.1093\/ageing\/afab211.","journal-title":"Age Ageing"},{"issue":"6","key":"3417_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/CCO.0000000000000792","volume":"33","author":"M M\u00f6ller","year":"2021","unstructured":"M\u00f6ller M, Gengenbach L, Graziani G, Greil C, W\u00e4sch R, Engelhardt M. Geriatric assessments and frailty scores in multiple myeloma patients: a needed tool for individualized treatment? Curr Opin Oncol. 2021;33(6):648\u201357. https:\/\/doi.org\/10.1097\/CCO.0000000000000792.","journal-title":"Curr Opin Oncol"},{"key":"3417_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101666","volume":"80","author":"P Doody","year":"2022","unstructured":"Doody P, Asamane EA, Aunger JA, Swales B, Lord JM, Greig CA, et al. The prevalence of frailty and pre-frailty among geriatric hospital inpatients and its association with economic prosperity and healthcare expenditure: a systematic review and meta-analysis of 467,779 geriatric hospital inpatients. Ageing Res Rev. 2022;80:101666. https:\/\/doi.org\/10.1016\/j.arr.2022.101666.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"3417_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s40122-020-00202-3","volume":"9","author":"I Ardoino","year":"2020","unstructured":"Ardoino I, Franchi C, Nobili A, Mannucci PM, Corli O, Reposi I. Pain and frailty in hospitalized older adults. Pain Ther. 2020;9(2):727\u201340. https:\/\/doi.org\/10.1007\/s40122-020-00202-3.","journal-title":"Pain Ther"},{"key":"3417_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-015-9762-4","author":"E Garc\u00eda-Esquinas","year":"2015","unstructured":"Garc\u00eda-Esquinas E, Navas-Acien A, Rodr\u00edguez-Artalejo F. Exposure to secondhand tobacco smoke and the frailty syndrome in US older adults. Age. 2015. https:\/\/doi.org\/10.1007\/s11357-015-9762-4.","journal-title":"Age"},{"issue":"Suppl 7","key":"3417_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00508-016-1087-5","volume":"128","author":"JE Morley","year":"2016","unstructured":"Morley JE. Frailty and sarcopenia in elderly. Wien Klin Wochenschr. 2016;128(Suppl 7):439\u201345. https:\/\/doi.org\/10.1007\/s00508-016-1087-5.","journal-title":"Wien Klin Wochenschr"},{"issue":"19","key":"3417_CR24","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.3390\/nu15194210","volume":"15","author":"L Li","year":"2023","unstructured":"Li L, Wu M, Yu Z, Niu T. Nutritional status indices and monoclonal gammopathy of undetermined significance risk in the elderly population: findings from the national health and nutrition examination survey. Nutrients. 2023;15(19):4210. https:\/\/doi.org\/10.3390\/nu15194210.","journal-title":"Nutrients"},{"issue":"11","key":"3417_CR25","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","volume":"81","author":"MM Kittleson","year":"2023","unstructured":"Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK, Clarke JO, et al. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient\u00a0with cardiac amyloidosis. J Am Coll Cardiol. 2023;81(11):1076\u2013126. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.022.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3417_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/jpen.2097","volume":"46","author":"X Wang","year":"2022","unstructured":"Wang X, Feng H, Hui Y, Yu Z, Zhao T, Mao L, et al. Neutrophil-to-lymphocyte ratio is associated with malnutrition risk estimated by the royal free hospital\u2013nutritional prioritizing tool in hospitalized cirrhosis. JPEN J Parenter Enteral Nutr. 2022;46(1):123\u20139. https:\/\/doi.org\/10.1002\/jpen.2097.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"12","key":"3417_CR27","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SVP Rajkumar","year":"2014","unstructured":"Rajkumar SVP, Dimopoulos MAP, Palumbo AP, Blade JM, Merlini GPM, Mateos MM, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u201348. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5.","journal-title":"Lancet Oncol"},{"issue":"4","key":"3417_CR28","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s11845-022-03250-0","volume":"192","author":"Z Shimoni","year":"2023","unstructured":"Shimoni Z, Dusseldorp N, Cohen Y, Barnisan I, Froom P. The Norton scale is an important predictor of in-hospital mortality in internal medicine patients. Ir J Med Sci (1971 -). 2023;192(4):1947\u201352. https:\/\/doi.org\/10.1007\/s11845-022-03250-0.","journal-title":"Ir J Med Sci (1971 -)"},{"issue":"6","key":"3417_CR29","doi-asserted-by":"publisher","first-page":"M366","DOI":"10.1093\/gerona\/56.6.m366","volume":"56","author":"LZ Rubenstein","year":"2001","unstructured":"Rubenstein LZ, Harker JO, Salva A, Guigoz Y, Vellas B. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (mna-sf). J Gerontol A Biol Sci Med Sci. 2001;56(6):M366\u201372. https:\/\/doi.org\/10.1093\/gerona\/56.6.m366.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"3417_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2020.101409","volume":"56","author":"MP Mogavero","year":"2021","unstructured":"Mogavero MP, Delrosso LM, Fanfulla F, Bruni O, Ferri R. Sleep disorders and cancer: state of the art and future perspectives. Sleep Med Rev. 2021;56:101409. https:\/\/doi.org\/10.1016\/j.smrv.2020.101409.","journal-title":"Sleep Med Rev"},{"key":"3417_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-017-0621-2","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017. https:\/\/doi.org\/10.1186\/s12877-017-0621-2.","journal-title":"BMC Geriatr"},{"issue":"21","key":"3417_CR32","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0713.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3417_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322.","journal-title":"J Stat Softw"},{"issue":"1","key":"3417_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12967-023-04029-2","volume":"21","author":"P Zhao","year":"2023","unstructured":"Zhao P, Zhen H, Zhao H, Huang Y, Cao B. Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets. J Transl Med. 2023;21(1):176. https:\/\/doi.org\/10.1186\/s12967-023-04029-2.","journal-title":"J Transl Med"},{"issue":"1","key":"3417_CR35","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/16078454.2022.2078040","volume":"27","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Chen Q, Lu C, Yu L. Prognostic role of controlling nutritional status score in hematological malignancies. Hematology. 2022;27(1):653\u20138. https:\/\/doi.org\/10.1080\/16078454.2022.2078040.","journal-title":"Hematology"},{"key":"3417_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/JIR.S390279","volume":"16","author":"L Zhang","year":"2023","unstructured":"Zhang L, Chen S, Wang W, Wang Y, Liang Y. Inflammatory and nutritional scoring system for predicting prognosis in patients with newly diagnosed multiple myeloma. J Inflamm Res. 2023;16:7\u201317. https:\/\/doi.org\/10.2147\/JIR.S390279.","journal-title":"J Inflamm Res"},{"issue":"1","key":"3417_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00277-022-05059-4","volume":"102","author":"L Zhang","year":"2023","unstructured":"Zhang L, Chen S, Huang M, Wang W, Liang Y, Wang Y. Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma. Ann Hematol. 2023;102(1):125\u201332. https:\/\/doi.org\/10.1007\/s00277-022-05059-4.","journal-title":"Ann Hematol"},{"key":"3417_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.nut.2016.06.009","volume":"36","author":"HS Kim","year":"2017","unstructured":"Kim HS, Lee JY, Lim SH, Cho J, Kim SJ, Jang JH, et al. Patient-generated subjective global assessment as a prognosis tool in patients with multiple myeloma. Nutrition. 2017;36:67\u201371. https:\/\/doi.org\/10.1016\/j.nut.2016.06.009.","journal-title":"Nutrition"},{"key":"3417_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03225-7","author":"J Shi","year":"2023","unstructured":"Shi J, Liu T, Ge Y, Liu C, Zhang Q, Xie H, et al. Cholesterol-modified prognostic nutritional index (cpni) as an effective tool for assessing the nutrition status and predicting survival in patients with breast cancer. BMC Med. 2023. https:\/\/doi.org\/10.1186\/s12916-023-03225-7.","journal-title":"BMC Med"},{"issue":"8","key":"3417_CR40","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3390\/nu15081991","volume":"15","author":"B Jab\u0142o\u0144ska","year":"2023","unstructured":"Jab\u0142o\u0144ska B, Mrowiec S. Nutritional status and its detection in patients with inflammatory bowel diseases. Nutrients. 2023;15(8):1991. https:\/\/doi.org\/10.3390\/nu15081991.","journal-title":"Nutrients"},{"issue":"4","key":"3417_CR41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3760\/cma.j.issn.0253-2727.2021.04.011","volume":"42","author":"F Liang","year":"2021","unstructured":"Liang F, Dong XY, Tang GF, Qi KM, Chen W, Sang W, et al. Influence of prognostic nutritional index and controlling nutritional status on the prognosis of patients with multiple myeloma. Zhonghua Xue Ye Xue Za Zhi. 2021;42(4):332\u20137. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2021.04.011.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"17","key":"3417_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175434","volume":"12","author":"HI Ellez","year":"2023","unstructured":"Ellez HI, Keskinkilic M, Semiz HS, Arayici ME, K\u0131sa E, Oztop I. The prognostic nutritional index (PNI): a new biomarker for determining prognosis in metastatic castration-sensitive prostate carcinoma. J Clin Med. 2023;12(17):5434. https:\/\/doi.org\/10.3390\/jcm12175434.","journal-title":"J Clin Med"},{"issue":"4","key":"3417_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/SLA.0000000000002985","volume":"271","author":"K Okadome","year":"2020","unstructured":"Okadome K, Baba Y, Yagi T, Kiyozumi Y, Ishimoto T, Iwatsuki M, et al. Prognostic nutritional index, tumor-infiltrating lymphocytes, and prognosis in patients with esophageal cancer. Ann Surg. 2020;271(4):693\u2013700. https:\/\/doi.org\/10.1097\/SLA.0000000000002985.","journal-title":"Ann Surg"},{"issue":"7","key":"3417_CR44","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/cam4.1128","volume":"6","author":"H Gregersen","year":"2017","unstructured":"Gregersen H, Vangsted AJ, Abildgaard N, Andersen NF, Pedersen RS, Frolund UC, et al. The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study. Cancer Med. 2017;6(7):1807\u201316. https:\/\/doi.org\/10.1002\/cam4.1128.","journal-title":"Cancer Med"},{"issue":"7","key":"3417_CR45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.clml.2015.03.004","volume":"15","author":"J Bila","year":"2015","unstructured":"Bila J, Jelicic J, Djurasinovic V, Vukovic V, Sretenovic A, Andjelic B, et al. Prognostic effect of comorbidity indices in elderly patients with multiple myeloma. Clin Lymphoma Myeloma Leuk. 2015;15(7):416\u20139. https:\/\/doi.org\/10.1016\/j.clml.2015.03.004.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"3417_CR46","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s12288-015-0618-y","volume":"32","author":"B Onec","year":"2016","unstructured":"Onec B, Okutan H, Albayrak M, Can ES, Aslan V, Soyer Kosemehmetoglu O, et al. Comparative evaluation of common comorbidity scores and Freiburger comorbidity index as prognostic variables in a real life multiple myeloma population. Indian J Hematol Blood Transfus. 2016;32(4):424\u201330. https:\/\/doi.org\/10.1007\/s12288-015-0618-y.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"7","key":"3417_CR47","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00277-021-04484-1","volume":"100","author":"Z Hou","year":"2021","unstructured":"Hou Z, Kang Y, Yang G, Wang Z, Wang F, Yu Y, et al. Pleural effusion-based nomogram to predict outcomes in unselected patients with multiple myeloma: a large single center experience. Ann Hematol. 2021;100(7):1789\u2013801. https:\/\/doi.org\/10.1007\/s00277-021-04484-1.","journal-title":"Ann Hematol"},{"key":"3417_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2645-y","author":"S Jung","year":"2016","unstructured":"Jung S, Cho M, Kim HK, Kim SJ, Kim K, Cheong J, et al. Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen. BMC Cancer. 2016. https:\/\/doi.org\/10.1186\/s12885-016-2645-y.","journal-title":"BMC Cancer"},{"issue":"5","key":"3417_CR49","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/imj.16049","volume":"53","author":"S Sim","year":"2023","unstructured":"Sim S, Kalff A, Tuch G, Mollee P, Ho PJ, Harrison S, et al. The importance of frailty assessment in multiple myeloma: a position statement from the myeloma scientific advisory group to myeloma Australia. Intern Med J. 2023;53(5):819\u201324. https:\/\/doi.org\/10.1111\/imj.16049.","journal-title":"Intern Med J"},{"issue":"3","key":"3417_CR50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.clml.2023.10.009","volume":"24","author":"A Oriol","year":"2024","unstructured":"Oriol A, Dimopoulos M, Schjesvold F, Beksac M, Facon T, Dhanasiri S, et al. Pomalidomide, bortezomib, and dexamethasone in lenalidomide-pretreated multiple myeloma: a subanalysis of optimismm by frailty and bortezomib dose adjustment. Clin Lymphoma Myeloma Leuk. 2024;24(3):165\u201376. https:\/\/doi.org\/10.1016\/j.clml.2023.10.009.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"3417_CR51","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4274\/tjh.galenos.2019.2019.0306","volume":"36","author":"S Cho","year":"2019","unstructured":"Cho S, Shin H, Jung KS, Kim DY. Dose adjustment helps obtain better outcomes in multiple myeloma patients with bortezomib, melphalan, and prednisolone (vmp) treatment. Turk J Hematol. 2019;36(2):106\u201311. https:\/\/doi.org\/10.4274\/tjh.galenos.2019.2019.0306.","journal-title":"Turk J Hematol"},{"issue":"3","key":"3417_CR52","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/S2352-3026(19)30011-0","volume":"6","author":"S Zweegman","year":"2019","unstructured":"Zweegman S, Larocca A. Frailty in multiple myeloma: the need for harmony to prevent doing harm. Lancet Haematol. 2019;6(3):e117\u20138. https:\/\/doi.org\/10.1016\/S2352-3026(19)30011-0.","journal-title":"Lancet Haematol"},{"key":"3417_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.612696","volume":"8","author":"NM Kaweme","year":"2021","unstructured":"Kaweme NM, Changwe GJ, Zhou F. Approaches and challenges in the management of multiple myeloma in the very old: future treatment prospects. Front Med. 2021;8:612696. https:\/\/doi.org\/10.3389\/fmed.2021.612696.","journal-title":"Front Med"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03417-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03417-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03417-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T17:40:10Z","timestamp":1768844410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03417-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3417"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03417-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the tenets of the Declaration of Helsinki and was approved by the Ethics Committee of Xijing hospital. All patients provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}